FDA Approvals: Scholar Rock’s SMA therapy Isembyld (apitegromab) wins FDA approval for adults and children 2+ already on SMN2-targeted treatments, reshaping a fast-evolving SMA market. Imaging & Diagnostics: FDA also approved Telix’s new brain cancer imaging agent Pixclara, aiming to improve glioma detection and treatment planning. Pharma Deals: GE HealthCare is reportedly in talks to buy radiopharma firm Sophie Biosciences for $1B, signaling continued consolidation in imaging and theranostics. Healthcare Business: Frazier Healthcare Partners names Jonathan Lujan CEO of MatrixCare after its acquisition from Resmed, targeting growth in post-acute EHR and revenue cycle tech. Public Health: Pennsylvania reports another measles-related death amid an outbreak, while EU leaders push the KIDS Act to tighten minors’ social media safety. Care Access: Iowa EMS seeks a grant to bring paramedic-style care into rural homes. Wellness & Research: Studies link higher vitamin D intake to better cognition in mild cognitive impairment, and gut bacteria may help protect against cardiovascular risk by converting dietary nitrate and iron. Sports Medicine Oddity: A HYROX athlete’s reported bowel accident sparks discussion of faecal incontinence and race-day realities.